Stella Xu Net Worth & Insider Trades

Stella Xu - Director, Design Therapeutics, Inc

As of June 2, 2023

What is Stella Xu's Net Worth?

The current estimated net worth of Design Therapeutics, Inc's Director, Stella Xu, is estimated to be about $25.39M . Stella Xu owns about 4,139,950 units of Design Therapeutics, Inc common stock. In the last 2 years at Design Therapeutics, Inc, Stella Xu has sold an estimated value of $11.27M worth.

What is Stella Xu's Past Insider Trading?

Stella Xu's largest purchase order was 4,730,830 units , worth over $200K on April 1, 2021. Stella Xu's largest sale order was 590,880 units , worth over $11.27M on March 22, 2022. In total, Stella Xu has made about 5 transactions over 2 years of their time at Design Therapeutics, Inc. Stella Xu usually trades in March and June, with the busiest year in 2022 and 2021.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Stella Xu's' Mailing Address?

  • Mailing address is C/o Armo Biosciences, Inc. 575 Chesapeake Drive Redwood City CA 94063 CA

What are Design Therapeutics, Inc's Past Insider Trades?

Design Therapeutics, Inc's most recent insider trade came on October 2, 2023 by Rodney Lappe who bought 21,000 units worth $49.29K . In the last 2 years, insiders at Design Therapeutics, Inc have sold an estimated value of $11.27M and bought an estimated value of $62.08M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Arsani William, Director,  Rodney Lappe, Director,  and Deepa Prasad, Director .

Design Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...